Coeptis Therapeutics (COEP) Insider Trading & Ownership → Biden replacement revealed? (From Paradigm Press) (Ad) Free COEP Stock Alerts $0.31 -0.02 (-6.04%) (As of 04/30/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Coeptis Therapeutics (NASDAQ:COEP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage21.49%Number OfInsiders Buying(Last 12 Months)6Amount OfInsider Buying(Last 12 Months)$77,835.64Number OfInsiders Selling(Last 12 Months)0 Get COEP Insider Trade Alerts Want to know when executives and insiders are buying or selling Coeptis Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COEP Insider Buying and Selling by Quarter Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Coeptis Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Tara DesilvaDirectorBuy2,266$0.58$1,314.28 1/10/2024Brian CogleyCFOBuy5,000$0.67$3,350.00 1/8/2024David MehalickCEOBuy20,004$0.66$13,202.64 1/5/2024Daniel Alexander YeraceVPBuy10,850$0.69$7,486.50 1/5/2024David MehalickCEOBuy5,050$0.69$3,484.50 1/5/2024Gene SalkindDirectorBuy11,600$0.69$8,004.00 8/29/2023Gene SalkindDirectorBuy4,006$1.01$4,046.06 8/25/2023Gene SalkindDirectorBuy28,638$0.91$26,060.58 8/23/2023Chris CaliseDirectorBuy11,582$0.94$10,887.08 (Data available from 1/1/2013 forward) COEP Insider Trading Activity - Frequently Asked Questions Who is on Coeptis Therapeutics's Insider Roster? The list of insiders at Coeptis Therapeutics includes Brian Cogley, Chris Calise, Daniel Alexander Yerace, David Mehalick, Gene Salkind, and Tara Desilva. Learn more on insiders at COEP. What percentage of Coeptis Therapeutics stock is owned by insiders? 21.49% of Coeptis Therapeutics stock is owned by insiders. Learn more on COEP's insider holdings. Which Coeptis Therapeutics insiders have been buying company stock? The following insiders have purchased COEP shares in the last 24 months: Brian Cogley ($3,350.00), Chris Calise ($10,887.08), Daniel Alexander Yerace ($7,486.50), David Mehalick ($16,687.14), Gene Salkind ($38,110.64), and Tara Desilva ($1,314.28). How much insider buying is happening at Coeptis Therapeutics? Insiders have purchased a total of 98,996 COEP shares in the last 24 months for a total of $77,835.64 bought. More Insider Trading Tools from MarketBeat Related Companies: Organovo Insider Trades BioCardia Insider Trades Inhibikase Therapeutics Insider Trades Sorrento Therapeutics Insider Trades Titan Pharmaceuticals Insider Trades Creative Medical Technology Insider Trades Fresh Tracks Therapeutics Insider Trades Palisade Bio Insider Trades TRACON Pharmaceuticals Insider Trades Finch Therapeutics Group Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:COEP) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPub#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm Press4 coins to be the “Next Bitcoin”True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
